Impact of COPD in North America and Europe in 2000: Subjects' perspective of Confronting COPD International Survey

European Respiratory Journal

Volumn 20, Issue 4, 2002, Pages 799-805

  Rennard, S ^a   Decramer, M ^a   Calverley, P M A ^a   Pride, N B ^a   Soriano, J B ^a   Vermeire, P A ^a   Vestbo, J ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Chronic obstructive pulmonary disease; Epidemiology; Guidelines; Management; Subject perspective

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DYSPNEA; EMPHYSEMA; EUROPE; FEMALE; HEALTH SERVICE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MORBIDITY; NORTH AMERICA; POPULATION RESEARCH; PRIORITY JOURNAL; RATING SCALE; SELF CONCEPT; SYMPTOMATOLOGY; UNEMPLOYMENT; WALKING;

AGE DISTRIBUTION; AGED; EUROPE; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; NORTH AMERICA; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 0036798971     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.02.03242002     Document Type: Article

References (33)

1. World Health Organization. The World Heath Report 1998. Life in the 21st Century. A Vision for All. Geneva, World Health Organization, 1998.
2. Murray CJ, Lopez AD. Alternative projection of mortality by cause 1990-2020: global burden of disease study. Lancet 1997; 349: 1498-1504.
3. Friedman M, Hilleman DE. Economic burden of chronic obstructive pulmonary disease. Impact of new treatment options. Pharmacoeconomics 2001; 19: 245-254.
4. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000; 117: 5S-9S.
5. Silverman EK, Speizer FE. Risk factors for the development of chronic obstructive pulmonary disease. Med Clin North Am 1996; 80: 501-522.
6. International Study of Asthma and Allergy in Childhood. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergy in Childhood (ISAAC). Eur Respir J 1998; 12: 315-335.
7. Burney P, Chinn S, Jarvis D. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medications in the European Community Respiratory Health Survey. Eur Respir J 1996; 9: 687-695.
8. Gulsvik A. Mortality in and prevalence of chronic obstructive pulmonary disease in different parts of Europe. Monaldi Arch Chest Dis 1999; 54: 160-162.
9. Kim N, Leeper KV. Epidemiology of chronic bronchitis and acute infective exacerbations of chronic bronchitis. Semin Respir Crit Care 2000; 21: 73-78.
10. Chen JC, Mannino DM. Worldwide epidemiology of chronic obstructive pulmonary disease. Curr Opin Pulm Med 1999; 5: 93-99.
11. Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest 2000; 117: 1S-4S.
12. British Lung Foundation. Chronic obstructive pulmonary disease. London, British Lung Foundation, 1999.
13. Lynn J, Ely EW, Zhong Z, et al. Living and dying with chronic obstructive pulmonary disease. J Am Geriatr Soc 2000; 48: S91-S100.
14. Rossi A, Confalonieri M. Burden of chronic obstructive pulmonary disease. Lancet 2000; 356: Suppl., s56.
15. Viegi G, Scognamiglio A, Baldacci S, Pistelli F, Carrozzi L. Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 2001; 68: 4-19.
16. Anto JM, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J 2001; 17: 982-994.
17. Fabbri L, Caramori G, Beghe B, Papi A, Ciaccia A. Chronic obstructive pulmonary disease international guidelines. Curr Opin Pulm Med 1998; 4: 76-84.
18. Lacasse Y, Ferreira I, Brooks D, Newman T, Goldstein RS. Critical appraisal of clinical practice guidelines targeting chronic obstructive pulmonary disease. Arch Intern Med 2001; 161: 69-74.
19. Grossman RF. Use of guidelines and risk stratification in acute exacerbations of chronic obstructive pulmonary disease. Semin Respir Crit Care 2000; 21: 113-122.
20. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
21. Hurd S. International efforts directed at attacking the problem of COPD. Chest 2001; 117: 336S-338S.
22. Gross NJ. The GOLD standard for chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1047-1048.
23. International Telecommunications Union. World Telecommunications Indicators: 2000-2001. Geneva, International Telecommunications Union, 2001.
24. Potthoff RF. Telephone sampling in epidemiologic research: to reap the benefits, avoid the pitfalls. Am J Epidemiol 1994; 139: 967-978.
25. Waksberg J. Sampling methods for random digit dialing. J Am Stat Assoc 1978; 73: 40-46.
26. Ferris BG. Epidemiology standardization project. Am Rev Respir Dis 1979; 118: 1S-120S.
27. Toren J, Brisman J, Jarvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires. Chest 1993; 104: 600-608.
28. Galobardes B, Sunyer J, Anto JM, Castellsague J, Soriano JB, Tobias A. Effect of the method of administration, mail or telephone, on the validity and reliability of a respiratory health questionnaire. The Spanish Centers of the European Asthma Study. J Clin Epidemiol 1998; 51: 875-881.
29. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586.
30. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000; 160: 1683-1689.
31. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16: 802-807.
32. Coultas DB, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001; 164: 372-377.
33. Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997; 10: 822-827.